For those staying after the CRL...

Quote

anonymous

Guest
Why? Nowhere else to go?
 

If you don't think everyone with a brain at LEO isn't polishing their resume and practicing their interviewing right now then you're about as dumb as someone who comes to another company's page to kick them while they're down.
 
anonymous said:
Damn. What exactly did the FDA reject?

Is this a temporary delay due to drug/device?
Click to expand...

its a rejection, but leo is going to resubmit application with some new data, apparently it’s only on the device but after 5 months of CP and team lying about this, they have zero credibility.

anyone else catch the global town hall where someone asked “hey what does the timeframe now look like” and CP said “I don’t know I’ll share it when I do” and then some global guy answered directly right after “actually we are thinking 6-12 months” or something like that.
 
anonymous said:
Layoffs? Are you serious? Is it just going to be the expansion positions and we go back to 85? Or is it going to be deeper than that?
Click to expand...

I was told GB got promised no layoffs or resizes for 12 months post launch, the layoffs will come from the bloated office. Forecast got burned down and there is no pipeline, a lot of teams overhired because Chris okayed every headcount request without thinking.
 
anonymous said:
LOL c'mon y'all, sales are through the roof plus we just brought on an investor, you think the company is in bad space? We are going to be just fine, give it some time.
Click to expand...

Share is flat. The "beating expectations" is because the expectation was that topicals would fall off a cliff and because our idiots in analytics thought the market would stay COVID small forever.

Sales knows it's in trouble. Huge increase in the sales team and yet no increase in share in new territories, no share increase overall, nothing since Duobrii fell off when they stopped giving their product away.
 


Write your reply...
Top Bottom
Back
Quote